COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 16:00, il y a 11 mois 2 jours Form 8.3 - Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclose 0.04% interest in Avadel Pharmaceuticals plc as of 19th November 2025. No other party involved. No dealings reported Disclosure Dealings Interests Zürcher Kantonalbank Avadel Pharmaceuticals Plc
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:55, il y a 11 mois 2 jours Original-Research: SFC Energy AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research has updated its analysis on SFC Energy AG, lowering the price target to €21 and confirming the Buy recommendation. The Q3 results were weaker compared to the previous year First Berlin Equity Research Buy Recommendation Research Update SFC Energy AG Price Target
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:51, il y a 11 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.67% stake in Qualcomm Incorporated as of 19 November 2025. Purchase and sale of USD 0.0001 common shares The Vanguard Group Stake Disclosure Stock Transactions Investment Disclosure Qualcomm Incorporated
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:50, il y a 11 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.47% stake in American Axle & Manufacturing Holdings, Inc. as per Form 8.3 under the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure American Axle
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:48, il y a 11 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.05% position in JTC plc's 1p ordinary securities as of 19 November 2025 Position Disclosure The Vanguard Group 1p Ordinary Securities 5.05% JTC Plc
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:46, il y a 11 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group discloses a 5.71% stake in Avadel Pharmaceuticals plc. Form 8.3 submitted to the Irish Takeover Panel on 20-Nov-2025 Form 8.3 Irish Takeover Panel Vanguard Group Stake Disclosure Avadel Pharmaceuticals Plc
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:45, il y a 11 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% interest in Mural Oncology plc as per Form 8.3 to the Irish Takeover Panel Form 8.3 Irish Takeover Panel Vanguard Group Interest Disclosure Mural Oncology Plc
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:44, il y a 11 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.33% stake in Greencore Group plc. Additional disclosure for Bakkavor Group plc. Purchase and sale details included Vanguard Group Stake Disclosure Purchase And Sale Greencore Group Plc Bakkavor Group Plc
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:43, il y a 11 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses owning 1.23% of Bluefield Solar Income Fund Limited's ordinary securities as of 19 Nov 2025 Securities Vanguard Group Ownership Disclosure Financial Disclosure Bluefield Solar Income Fund
COMMUNIQUÉ DE PRESSE publié le 20/11/2025 à 15:41, il y a 11 mois 2 jours Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.57% interest in Spire Healthcare Group plc per Form 8.3. Details of securities dealt & positions held disclosed Securities The Vanguard Group, Inc. Form 8.3 Positions Spire Healthcare Group Plc
Publié le 22/10/2026 à 18:00, il y a 4 heures 11 minutes THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Publié le 22/10/2026 à 18:00, il y a 4 heures 11 minutes THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Publié le 22/10/2026 à 18:00, il y a 4 heures 11 minutes bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Publié le 22/10/2026 à 18:00, il y a 4 heures 11 minutes bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Publié le 22/10/2026 à 18:00, il y a 4 heures 11 minutes 1er semestre 2026 : résultats opérationnels en nette amélioration
Publié le 22/10/2026 à 16:00, il y a 6 heures 11 minutes Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Publié le 22/10/2026 à 14:30, il y a 7 heures 41 minutes Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Publié le 22/10/2026 à 14:00, il y a 8 heures 11 minutes Jericho Energy Ventures Amends Investor Relations Agreement with Orange Group Advisors
Publié le 22/10/2026 à 14:00, il y a 8 heures 11 minutes Viemed Healthcare Announces Third Quarter 2026 Earnings Conference Call Details
Publié le 22/10/2026 à 13:45, il y a 8 heures 26 minutes Karbon-X (OTCQB:KARX) Accelerates High-Margin Transformation in Q1 FY2027: Gross Margin Expands to 32%, Operating Cash Burn Drops 55%, and Deferred Revenue Reaches $4.3 Million
Publié le 22/10/2026 à 20:00, il y a 2 heures 11 minutes Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Publié le 22/10/2026 à 19:45, il y a 2 heures 26 minutes EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Publié le 22/10/2026 à 18:45, il y a 3 heures 26 minutes Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Publié le 22/10/2026 à 18:30, il y a 3 heures 41 minutes lePERMISLIBRE annonce l’organisation d’une visioconférence destinée aux actionnaires et investisseurs
Publié le 22/10/2026 à 18:12, il y a 3 heures 59 minutes LION E-Mobility AG: CEO Dr. Joachim Damasky to retire at the end of January 2027
